Storia in 15 fonti

Markets start August on a high with big pharma merger talks grabbing the headlines

AstraZeneca looking at merger with Bristol Myers Squibb to create fourth largest pharma group

Raccontata da

businessday.co.za+3 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

irishtimes.comStai leggendo15 h fa

Markets start August on a high with big pharma merger talks grabbing the headlines

AstraZeneca in €350B acquisition talks with Bristol Myers Squibb (world's #4 pharma), but markets doubted logic (-9% stock). Pharma consolidation plus SpaceX earnings and AI-company reports this week signal M&A window and tech valuation reset.

originale

Timeline cronologica

domenica 2 agosto 2026·handelsblatt.com
Pharma: AstraZeneca erwägt Mega-Fusion mit US-Rivalen Bristol Myers Squibb
Es wäre eine der größten Fusionen in der Wirtschaftsgeschichte. Laut einem Medienbericht wurden entsprechende Gespräche geführt. Ob es zu einem Zusammenschluss kommt ist jedoch…
domenica 2 agosto 2026·straitstimes.com
Pharma giants AstraZeneca, Bristol Myers Squibb in talks on $512 billion megadeal: Report
The deal could create one of the world’s biggest pharmaceutical groups with a combined value of nearly US$400 billion. Read more at straitstimes.com. Read more at straitstimes.com.

Markets start August on a high with big pharma merger talks grabbing the headlines

Confronto fonti

Markets start August on a high with big pharma merger talks grabbing the headlines

Timeline cronologica

Pharma: AstraZeneca erwägt Mega-Fusion mit US-Rivalen Bristol Myers Squibb

Pharma giants AstraZeneca, Bristol Myers Squibb in talks on $512 billion megadeal: Report

Pharma giants AstraZeneca and Bristol-Myers in reported merger talks

AstraZeneca shares fall amid reports of $400bn Bristol Myers Squibb merger talks

FT: AstraZeneca and Bristol-Myers Squibb plan $400bn merger

UK's AstraZeneca eyeing $400b merger, report says

AstraZeneca, Bristol Myers are in talks about merger — report

AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger - AstraZeneca (NYSE:AZN)

AstraZeneca, Bristol Myers are in talks about merger — report

AstraZeneca said to have explored Bristol Myers merger | Fortune

An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.

Pharma: Astra-Zeneca erwägt wohl Mega-Fusion mit Bristol-Myers Squibb

Astrazeneca explores $400bn megadeal with US rival

AstraZeneca in talks over £300bn mega-merger with US rival – reports

AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb

AstraZeneca, BMS discuss $400B pharma mega-deal

AstraZeneca ‘in talks to create £300bn pharmaceutical giant’

AstraZeneca share prices drop amid £300bn mega-merger talks with US rival

Astrazeneca share price tumbles as investors doubt merger with US rival

$400 Billion Pharma Megadeal? Jefferies Calls Potential AstraZeneca-Bristol Myers Merger A "Head Scratcher"

Why Is Bristol-Myers Squibb Stock Surging Monday? - Bristol-Myers Squibb (NYSE:BMY), AstraZeneca (NYSE:AZ

AstraZeneca shares fall amid reports of $400bn Bristol Myers Squibb merger talks

Pharmalittle: We're reading about AstraZeneca-Bristol merger talks, a revised 340B plan, and more

AstraZeneca Stock Nosedives On Mega-Merger Rumor

Pharma giants AstraZeneca and Bristol-Myers in reported merger talks